Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)

Varsha M Patel,Kumudha Balakrishnan,Mark W. Douglas,Thomas T. Tibbitts,Eric You Xu,Jeffery L. Kutok,Mark Ayers,Abhishek Sarkar,Roberto Guerrieri,William G. Wierda,Susan OBrien,Neeraj Jain,Howard M. Stern,Varsha V Gandhi

Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)

2017

Varsha M Patel
Kumudha Balakrishnan
Mark W. Douglas
Thomas T. Tibbitts
Eric You Xu
Jeffery L. Kutok
Mark Ayers
Abhishek Sarkar
Roberto Guerrieri
William G. Wierda
Susan OBrien
Neeraj Jain
Howard M. Stern
Varsha V Gandhi

Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)

Keywords:

Chronic lymphocytic leukemia
Genetics
Cancer research
Sensitization
Apoptosis
Immunology
Duvelisib
Biology
Venetoclax
In vitro
Tumor microenvironment
Lymphoma
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations